Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Prepaid Assets (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Prepaid Assets for 10 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 34.92% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 34.92% year-over-year, with the annual reading at $3.8 million for FY2025, 34.92% down from the prior year.
  • Prepaid Assets hit $3.8 million in Q4 2025 for Rocket Pharmaceuticals, down from $4.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $14.8 million in Q1 2024 to a low of $3.3 million in Q4 2021.
  • Historically, Prepaid Assets has averaged $6.4 million across 5 years, with a median of $5.6 million in 2021.
  • Biggest five-year swings in Prepaid Assets: surged 176.12% in 2024 and later crashed 59.27% in 2025.
  • Year by year, Prepaid Assets stood at $3.3 million in 2021, then skyrocketed by 130.97% to $7.7 million in 2022, then crashed by 34.16% to $5.0 million in 2023, then grew by 15.85% to $5.8 million in 2024, then plummeted by 34.92% to $3.8 million in 2025.
  • Business Quant data shows Prepaid Assets for RCKT at $3.8 million in Q4 2025, $4.9 million in Q3 2025, and $5.7 million in Q2 2025.